These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26907189)

  • 1. IRF4 SNP is predictive of melanoma subtypes.
    Granovetter M
    Lancet Oncol; 2016 Mar; 17(3):e96. PubMed ID: 26907189
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
    Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
    Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
    Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 5. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
    Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
    Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort.
    Cho HG; Ransohoff KJ; Yang L; Hedlin H; Assimes T; Han J; Stefanick M; Tang JY; Sarin KY
    J Am Acad Dermatol; 2018 Jul; 79(1):36-41.e10. PubMed ID: 29499294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.
    Ward SV; Gibbs DC; Orlow I; Thomas NE; Kanetsky PA; Luo L; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Rosso S; Zanetti R; Dwyer T; Begg CB; Berwick M;
    Br J Dermatol; 2020 Jul; 183(1):163-165. PubMed ID: 31958143
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.
    Gibbs DC; Ward SV; Orlow I; Cadby G; Kanetsky PA; Luo L; Busam KJ; Kricker A; Armstrong BK; Cust AE; Anton-Culver H; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Ollila DW; Begg CB; Berwick M; Thomas NE;
    Br J Dermatol; 2017 Nov; 177(5):e180-e182. PubMed ID: 28667740
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
    Itin PH; Fistarol SK
    Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
    Duffy DL; Zhu G; Li X; Sanna M; Iles MM; Jacobs LC; Evans DM; Yazar S; Beesley J; Law MH; Kraft P; Visconti A; Taylor JC; Liu F; Wright MJ; Henders AK; Bowdler L; Glass D; Ikram MA; Uitterlinden AG; Madden PA; Heath AC; Nelson EC; Green AC; Chanock S; Barrett JH; Brown MA; Hayward NK; MacGregor S; Sturm RA; Hewitt AW; ; Kayser M; Hunter DJ; Newton Bishop JA; Spector TD; Montgomery GW; Mackey DA; Smith GD; Nijsten TE; Bishop DT; Bataille V; Falchi M; Han J; Martin NG
    Nat Commun; 2018 Nov; 9(1):4774. PubMed ID: 30429480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
    Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
    Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A piece of the melanoma puzzle.
    Goldstein AM; Tucker MA
    J Natl Cancer Inst; 2005 Oct; 97(20):1486-7. PubMed ID: 16234555
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of cutaneous melanoma. An update.
    Sober AJ; Lew RA; Koh HK; Barnhill RL
    Dermatol Clin; 1991 Oct; 9(4):617-29. PubMed ID: 1934636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for skin melanoma: genetic factors probably more important than exposure to sunlight].
    Pavel S; Smit NP
    Ned Tijdschr Geneeskd; 2004 Nov; 148(46):2267-72. PubMed ID: 15584541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a molecular classification of melanoma.
    Fecher LA; Cummings SD; Keefe MJ; Alani RM
    J Clin Oncol; 2007 Apr; 25(12):1606-20. PubMed ID: 17443002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Genome-Wide Association Study Identifies the Skin Color Genes IRF4, MC1R, ASIP, and BNC2 Influencing Facial Pigmented Spots.
    Jacobs LC; Hamer MA; Gunn DA; Deelen J; Lall JS; van Heemst D; Uh HW; Hofman A; Uitterlinden AG; Griffiths CEM; Beekman M; Slagboom PE; Kayser M; Liu F; Nijsten T
    J Invest Dermatol; 2015 Jul; 135(7):1735-1742. PubMed ID: 25705849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of associations between GWAS SNPs and melanoma risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
    Kocarnik JM; Park SL; Han J; Dumitrescu L; Cheng I; Wilkens LR; Schumacher FR; Kolonel L; Carlson CS; Crawford DC; Goodloe RJ; Dilks H; Baker P; Richardson D; Ambite JL; Song F; Quresh AA; Zhang M; Duggan D; Hutter C; Hindorff LA; Bush WS; Kooperberg C; Le Marchand L; Peters U
    J Invest Dermatol; 2014 Jul; 134(7):2049-2052. PubMed ID: 24480881
    [No Abstract]   [Full Text] [Related]  

  • 18. Genes Determining Nevus Count and Dermoscopic Appearance in Australian Melanoma Cases and Controls.
    Duffy DL; Jagirdar K; Lee KJ; McWhirter SR; McMeniman EK; De'Ambrosis B; Pflugfelder A; Rayner JE; Whiteman DC; Brown MA; Martin NG; Smithers BM; Schaider H; Soyer HP; Sturm RA
    J Invest Dermatol; 2020 Feb; 140(2):498-501.e17. PubMed ID: 31421127
    [No Abstract]   [Full Text] [Related]  

  • 19. MC1R germline variants confer risk for BRAF-mutant melanoma.
    Landi MT; Bauer J; Pfeiffer RM; Elder DE; Hulley B; Minghetti P; Calista D; Kanetsky PA; Pinkel D; Bastian BC
    Science; 2006 Jul; 313(5786):521-2. PubMed ID: 16809487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma.
    Ung-Juurlink C
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):461-2. PubMed ID: 10507913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.